Stage III membranous nephropathy usually has a poor prognosis and is unlikely to be cured, but partial or complete remission may be achieved with standardized treatment as prescribed by the doctor.
Membranous nephropathy occurs in middle-aged and old people, especially in men. Membranous nephropathy has an insidious onset, and most patients present with nephrotic syndrome and a high incidence of arteriovenous thrombosis. Some patients with membranous nephropathy have a tendency to remit on their own. Stage 1 patients can be relieved or even recovered, while stage 2 patients have a better prognosis, and stage 3 and 4 patients have a poor prognosis.
Patients with Stage III membranous nephropathy should receive active supportive therapy, and immunosuppressive drugs (such as cyclosporine, cyclophosphamide) or rituximab can be added according to the doctor’s prescription.
Patients diagnosed with membranous nephropathy should go to regular hospitals in time and follow the doctor’s instructions for standardized treatment to avoid delays.